Literature DB >> 26130406

The Role of Osmotic Therapy in Hemispheric Stroke.

C J Ong1, S G Keyrouz, M N Diringer.   

Abstract

BACKGROUND: Decompressive hemicraniectomy (DHC) can be lifesaving in hemispheric stroke complicated by cerebral edema. Conversely, osmotic agents have not been shown to improve survival, despite their widespread use. It is unknown whether medical measures can similarly confer survival in certain patient subgroups. We hypothesized that osmotic therapy (OT) without DHC may be associated with a greater likelihood of survival in particular populations depending on demographic, radiologic, or treatment characteristics.
METHODS: We performed a retrospective cohort analysis of patients with large anterior circulation strokes with an NIH stroke scale (NIHSS) ≥10 who received OT. We compared clinical, radiologic, and treatment characteristics between two groups: (1) those who survived until discharge with only OT (medical management success) and (2) those who required either DHC or died (medical management failure).
RESULTS: Thirty patients met eligibility criteria. Median NIHSS was 19 [interquartile range (IQR) 13-24], and median GCS was 10 [IQR 8-14]. Forty-seven percent of the medical management cohort survived to discharge. Demographic characteristics associated with medical management success included NIHSS (p = 0.009) and non-black race (p = 0.003). Of the various interventions, the administration of OT after 24 hours and a smaller hypertonic saline dose was also associated with survival to discharge (p = 0.038 and 0.031 respectively).
CONCLUSION: Our results suggest that patients with moderate size hemispheric infarcts on presentation and those who do not require OT within the first 24 h of stroke may survive until discharge with medical management alone. Black race was also associated with conservative management failure, a finding that may reflect a cultural preference toward aggressive management. Further prospective studies are needed to better establish the utility of medical management of hemispheric edema in the setting of moderate size hemispheric infarcts.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26130406     DOI: 10.1007/s12028-015-0173-2

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  22 in total

1.  Predictors of mortality in stroke patients admitted to an intensive care unit.

Authors:  G Rordorf; W Koroshetz; J T Efird; S C Cramer
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

2.  Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group.

Authors:  D Woo; J P Broderick; R U Kothari; M Lu; T Brott; P D Lyden; J R Marler; J C Grotta
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

3.  Ethnic disparities in end-of-life care after subarachnoid hemorrhage.

Authors:  H Alex Choi; Andres Fernandez; Sang-Beom Jeon; J Michael Schmidt; E Sander Connolly; Stephan A Mayer; Jan Claassen; Neeraj Badjatia; Kenneth M Prager; Kiwon Lee
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

4.  Predictors of malignant brain edema in middle cerebral artery infarction observed on CT angiography.

Authors:  Hoon Kim; Seon Tak Jin; Young Woo Kim; Seong Rim Kim; Ik Seong Park; Kwang Wook Jo
Journal:  J Clin Neurosci       Date:  2014-12-12       Impact factor: 1.961

Review 5.  Sinking skin flaps, paradoxical herniation, and external brain tamponade: a review of decompressive craniectomy management.

Authors:  Paul T Akins; Kern H Guppy
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

6.  Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial.

Authors:  Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp
Journal:  Lancet Neurol       Date:  2009-03-05       Impact factor: 44.182

7.  Mannitol use in acute stroke: case fatality at 30 days and 1 year.

Authors:  Dániel Bereczki; László Mihálka; Szabolcs Szatmári; Klára Fekete; David Di Cesar; Béla Fülesdi; László Csiba; István Fekete
Journal:  Stroke       Date:  2003-06-19       Impact factor: 7.914

8.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial.

Authors:  Eric Jüttler; Stefan Schwab; Peter Schmiedek; Andreas Unterberg; Michael Hennerici; Johannes Woitzik; Steffen Witte; Ekkehart Jenetzky; Werner Hacke
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

9.  Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial).

Authors:  Katayoun Vahedi; Eric Vicaut; Joaquim Mateo; Annie Kurtz; Mikael Orabi; Jean-Pierre Guichard; Carole Boutron; Gregory Couvreur; François Rouanet; Emmanuel Touzé; Benoît Guillon; Alexandre Carpentier; Alain Yelnik; Bernard George; Didier Payen; Marie-Germaine Bousser
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

Review 10.  Surgical decompression for cerebral oedema in acute ischaemic stroke.

Authors:  Salvador Cruz-Flores; Eivind Berge; Ian R Whittle
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18
View more
  4 in total

1.  Decompressive Hemicraniectomy in the Age of Personalized Medicine.

Authors:  Michael N Diringer
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

2.  Factors Associated with the Outcome of Very Elderly Patients with Large Hemispheric Infarction Treated with Medical Management Only.

Authors:  Sudhir Datar; Christopher McLouth; Patrick Reynolds
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

Review 3.  What is the Role of Hyperosmolar Therapy in Hemispheric Stroke Patients?

Authors:  Nathan Mohney; Omar Alkhatib; Sebastian Koch; Kristine O'Phelan; Amedeo Merenda
Journal:  Neurocrit Care       Date:  2020-04       Impact factor: 3.210

4.  Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.

Authors:  Aaron M Cook; G Morgan Jones; Gregory W J Hawryluk; Patrick Mailloux; Diane McLaughlin; Alexander Papangelou; Sophie Samuel; Sheri Tokumaru; Chitra Venkatasubramanian; Christopher Zacko; Lara L Zimmermann; Karen Hirsch; Lori Shutter
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.